Company intelligence / Profile preview

Indegene

Bangalore, Karnataka, Indiaindegene.com ↗

Ownership: Public · INDGN
Development stage: Other

Overview

Indegene enables biopharma, biotech, and medtech companies to accelerate product development and commercialization through digital-first strategies. It does not have its own clinical pipeline but supports clients across R&D, regulatory affairs, medical affairs, pharmacovigilance, marketing/commercialization with advanced technology solutions.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Major partnerships with leading global pharmaceutical and biotechnology firms—serving all top twenty global biopharma by revenue as clients since FY21.

Financials

Market cap: $1.6B
Total revenue: $374M
Enterprise value: $1.4B

Beyond the preview

Go deeper on Indegene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indegene.